What is ductal breast cancer?

Ductal breast cancer is a common type of breast cancer.

Ductal breast cancer originates from ductal epithelial cells of the breast. Abnormal proliferation and malignant transformation of these cells are important causes of ductal breast cancer. There may be no obvious symptoms in the early stage, but as the disease progresses, breast lumps, nipple discharge, breast skin changes, etc. may appear. Breast masses are usually hard, ill-defined, and poorly mobile. Nipple discharge may be bloody, serous, etc. The skin of the breast may show orange peel changes, dimples, etc.

The disease requires a combination of examination methods, such as breast ultrasound, mammography, magnetic resonance imaging (MRI), etc., as well as pathological biopsy to confirm the diagnosis. Pathological examination is the gold standard.

Treatment options include surgery, chemotherapy, radiotherapy, endocrine therapy and targeted therapy. Specific treatment options are individualized according to the patient's age, condition, physical condition and other factors. Surgery is one of the main treatment options, which may include total mastectomy or breast-conserving surgery. Chemotherapy is used to kill residual cancer cells, radiotherapy can reduce the risk of local recurrence, endocrine therapy is important for hormone receptor-positive patients, targeted therapy plays a role in specific targets.

Prognosis is related to a variety of factors, such as tumor stage, grade, timeliness and effectiveness of treatment. Early diagnosis and standardized treatment are essential to improve prognosis. At the same time, patient follow-up and rehabilitation are also very important, including regular follow-up and maintaining a healthy lifestyle.

For breast ductal cancer, vigilance should be raised and regular breast examination should be performed for early detection and early treatment, thus improving survival rate and quality of life.